SCHEMBL14880928

SCHEMBL14880928

Cc1cc(C)c2nc(Nc3ccc(Br)cc3)sc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 1/20 0.51
NPC1 O15118 5/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
RORC P51449 1/20 0.47
GAA P10253 2/20 0.47
HSD17B10 Q99714 1/20 0.46
RAB9A P51151 2/20 0.45
MAPT P10636 5/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 3/20 0.44
AHR P35869 1/20 0.43
MCL1 Q07820 1/20 0.43
SAE1 Q9UBE0 1/20 0.43
UBA2 Q9UBT2 1/20 0.43
DHODH Q02127 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HPGD P15428 1/20 0.42
NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4819924 0.78 RAPGEF4 (0.53) RAPGEF4NPC1MEN1KMT2ARAB9A
SCHEMBL12593865 0.78 NPC1 (0.60) NPC1MEN1KMT2ARAB9AMAPT
SCHEMBL14882198 0.77 NPC1 (0.42) NPC1MEN1KMT2ARORCGAA
SCHEMBL28128281 0.76 HSD17B10 (0.51) RAPGEF4NPC1MEN1KMT2ARORC
SCHEMBL14880926 0.74 ALDH1A1 (0.46) NPC1MEN1KMT2AGAAHSD17B10
SCHEMBL14880646 0.74 MEN1 (0.62) NPC1MEN1KMT2AGAARAB9A
SCHEMBL22074675 0.73 HSD17B10 (0.61) NPC1MEN1KMT2ARORCGAA
SCHEMBL14881104 0.72 KMT2A (0.59) NPC1MEN1KMT2AGAARAB9A
SCHEMBL14881170 0.72 MEN1 (0.46) NPC1MEN1KMT2AGAARAB9A
SCHEMBL14881154 0.70 ALDH1A1 (0.71) NPC1MEN1KMT2AGAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013056679-A1 NOVEL HETEROARYL-AMINO DERIVATIVES BEIJING HANMI PHARMACEUTICAL CO., LTD (CN) 2013-04-25 WO disclosed